Ann: Q1 2024 Investor Webinar Presentation, page-11

My take was nothing too new presented but I picked up mainly on the comments of multiples interested, however PYC is only interested in value related propositions or is happy to go it alone which echo's confidence in what they have for my take on this so I'm pleased with that from Management to wait it out to secure higher returns for SH's.
My other Q on the day was on the efficacy of RP11 timing which was hinted at likely prior to Dec so this would boost our SP considerably IMO if patients are seeing better and actual results not far away, not just data related, suggesting an attraction of a lot more local interest.
Suggest we will continue to bounce around on the SP a bit with no news until the cement begins to harden ! I guess its a possible opportunity really, dependant on the need and timing of any CR if required, & of course high dose tox & EOY efficacy results....
Still buying, still confident. GLTAH.